Group 7 Copy 3 Created with Sketch.

MENU
Centers
Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous
News Current Issue Archive Device Guide Calendar Subscribe Advertising About Contact Privacy Submissions

Advertisement

Search Results

Refine by Content Type

close Created with Sketch.

Refine by Year

close Created with Sketch.

Sort By:

Relevance Date

Choose Sites to Search:

EVToday EVToday + CIToday

evt | Article | July 2006

Preliminary Experience With DESs in Tibial Arteries

Sirolimus-eluting stents appear to be safe and effective in treating focal infrapopliteal obstructions.

By Dierk Scheinert, MD; Giancarlo Biamino, MD; and Andrej Schmidt, MD

evt | Article | October 2004

Excimer Laser to Treat SFA In-Stent Restenosis

Excimer laser-assisted recanalization of SFA in-stent restenosis simplifies reintervention on restenosed stents and may prevent complications.

By Giancarlo Biamino, MD

evt | Article | May/June 2003

Excimer Laser Treatment of SFA Occlusions

The combination of excimer laser technology with current interventional devices and advanced recanalization techniques offers certain advantages over standard PTA techniques.

By Giancarlo Biamino, MD, and Dierk Scheinert, MD

evt | News | August 18, 2013

Spectranetics Launches New Catheter Sizes for Turbo Elite 0.035 Laser Atherectomy Device to Treat CTOs

August 19, 2013—Spectranetics Corporation (Colorado Springs, CO) announced the launch of new catheter sizes for the Turbo Elite 0.035 laser atherectomy device.

Advertisement

evt | Article | October 2004

An Overview of Cryoplasty

Current and future applications of this technology show promising ability to resolve many of the troubling issues encountered in treating lower-extremity arterial disease.

By James D. Joye, DO

evt | Article | May/June 2003

Chief Medical Editor's Page

Defeating SFA Disease

By John R. Laird, Jr, MDChief Medical Editor

evt | Article | October 2004

Restenosis Management

By John R. Laird, Jr, MD Chief Medical Editor

evt | Article | September 2005

An Interview With Gary Ansel, MD

A top interventional cardiologist shares his insight on the future of SFA treatment and what to expect from VIVA 2005.

By Gary Ansel, MD

Advertisement

Cardiac Interventions Today
Group 7 Copy 3 Created with Sketch.
bmc-secondary-mark-color copy Created with Sketch.

© 2026 Bryn Mawr Communications II, LLC.  
All Rights Reserved   •   Privacy Policy

one-trust-button